Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands

Molecules

Volumn 18, Issue 1, 2013, Pages 154-166

  Rami, Marouan ^a   Landagaray, Elodie ^a   Ettaoussi, Mohamed ^a   Boukhalfa, Koussayla ^a   Caignard, Daniel Henri ^b   Delagrange, Philippe ^b   Berthelot, Pascal ^a   Yous, Saïd ^a  

^a UNIV LILLE   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Agomelatine; Agonist; Conformationally restriction; Melatonin

Indexed keywords

EID: 84872854994     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18010154     Document Type: Article

References (43)

1. Lerner, A.B.; Case, J.D.; Heinzelman, R.V. Structure of melatonin. J. Am. Chem. Soc. 1959, 81, 6084-6085.
2. Guerrero, J.M.; Reiter, R.J. Melatonin-Immune System Relationships. Curr. Top. Med. Chem. 2002, 2, 167-169.
3. Dubocovich, M.L.; Mansana, M.I.; Benloucif, S. Molecular pharmacology and function of melatonin receptor subtype. Adv. Exp. Med. Biol. 1999, 460, 181-190.
4. Malpaux, B.; Migaud, M.; Tricoire, H.; Chemineau, P. Biology of Mammalian Photoperiodism and the Critical Role of the Pineal Gland and Melatonin. J. Biol. Rhythms. 2001, 16, 336-347.
5. Reiter, R.J. The melatonin rhythm: Both a clock and a calendar. Experientia 1993, 49, 654-664.
6. Nosjean, O.; Ferro, M.; Coge, F.; Beauverger, P.; Henlin, J.M.; Lefoulon, F.; Fauchere, J.L.; Delagrange, P.; Canet, E.; Boutin, J.A. MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters. J. Biol. Chem. 2000, 275, 31311-31317.
7. Vella, F.; Ferry, G.; Delagrange, P.; Boutin, J.A.; NRH: Quinone reductase 2: An enzyme of surprises and mysteries. Biochem. Pharmacol. 2005, 71, 1-12.
8. Lotufo, C.M.C.; Lopes, C.; Dubocovich, M.L.; Farsky, S.H.P.; Markus, R.P. Melatonin and N-Acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur. J. Pharmacol. 2001, 430, 351-357.
9. Pintor, J.; Martin, L.; Pelaez, T.; Hoyle, C.H.V.; Peral, A. Involvement of melatonin MT3 receptors in the regulation of intraocular pressure in rabbits. Eur. J. Pharmacol. 2001, 416, 251-254.
10. Zlotos, D.P. Recent Advances in Melatonin Receptor Ligands. Arch. Pharm. Chem. Life Sci. 2005, 338, 229-247.
11. Garratt, P.J.; Tsotinis, A. Synthesis of compounds as melatonin agonists and antagonists. Mini-Rev. Med. Chem. 2007, 7, 1075-1088.
12. Carocci, A.; Catalano, A.; Lovece, A.; Lentini, G.; Duranti, A.; Lucini, V.; Pannacci, M.; Scaglione, F.; Franchini, C. Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors. Bioorg. Med. Chem. 2010, 18, 6496-6511.
13. Tsotinis, A.; Afroudakis, P.A.; Davidson, K.; Prashar, A.; Sugden, D. Design, Synthesis, and Melatoninergic Activity of New Azido- and Isothiocyanato-Substituted Indoles. J. Med. Chem. 2007, 50, 6436-6440.
14. Nonno, R.; Pannacci, M.; Lucini, V.; Angeloni, D.; Fraschini, F.; Stankov, B.M. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: Evidence for agonist activity of some MT1-Antagonists. Br. J. Pharmacol. 1999, 127, 1288-1294.
15. Fisher, S.P.; Sugden, D. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat. Neurosci. Lett. 2009, 457, 93-96.
16. Koike, T.; Hoashi, Y.; Takai, T.; Nakayama, M.; Yukuhiro, N.; Ishikawa, T.; Hirai, K.; Uchikawa, O. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: Design, synthesis and pharmacological characterization of a novel class of highly potent MT2-selective agonists. J. Med. Chem. 2011, 54, 3436-3444.
17. Ettaoussi, M.; Sabaouni, A.; Rami, M.; Boutin, J.A.; Delagrange, P.; Renard, P.; Spedding, M.; Caignard, D.H.; Berthelot, P.; Yous, S. Design, synthesis and pharmacological evaluation of new series of naphthalenicanalogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I). Eur. J. Med. Chem. 2012, 49, 310-323.
18. Markl, C.; Attia, M.I.; Julius, J.; Sethi, S.; Witt-Enderby, P.A.; Zlotos, D.P. Synthesis and pharmacological evaluation of 1,2,3,4- tetrahydropyrazino [1,2-A]indole and 2-[(phenylmethylamino) methyl]-1H-indole analogues as novel melatoninergic ligands. Bioorg. Med. Chem. 2009, 17, 4583-4594.
19. Attia, M.I.; Witt-Enderby, P.A.; Julius, J. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands. Bioorg. Med. Chem. 2008, 16, 7654-7661.
20. Simpson, D.; Curran, M.P. Ramelteon: A review of its use in Insomnia. Drugs 2008, 68, 1901-1919.
21. Montgomery, S.A. Major depressive disorders: Clinical efficacy and tolerability of agomelatine, a new melatonergicagonist. Eur. Neuropsychopharmacol. 2006, 16, S633-S638.
22. Dagyte, G.; Trentani, A.; Postema, F.; Luiten, P.G.; Den Boer, J.A.; Gabriel, C.; Mocaër, E.; Meerlo, P.; Van der Zee, E. The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats. CNS Neurosci. Ther. 2010, 16, 195-207.
23. Dagyte, G.; Luiten, P.G.; De Jager, T.; Gabriel, C.; Mocaër, E.; Den Boer, J.A.; Van der Zee, E. Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain. J. Neurosci. Res. 2011, 89, 1646-1657.
24. Mathé-Allainmat, M.; Andrieux, J.; Langlois, M. Recent developments in melatonin receptor ligands. Expert Opin. Ther. Pat. 1997, 7, 1447-1458.
25. Marot, C.; Chavatte, P.; Morin-Allory, L.; Guillaumet, G.; Viaud-Massuard, M.C.; Renard, P.; Lesieur, D.; Michel, A. Pharmacophoric Search and 3D-QSAR Comparative Molecular Field Analysis Studies on Agonists of Melatonin Sheep Receptors. J. Med. Chem. 1998, 41, 4453-4465.
26. Mésangeau, C.; Pérès, B.; Descamps-François, C.; Chavatte, P.; Audinot, V.; Coumailleau, S.; Boutin J.A.; Delagrange, P.; Bennejean, C.; Renard P.; et al. Design, synthesis and pharmacologicalevaluation of novelnaphthalenicderivatives as selective MT1 melatoninergic ligands. Bioorg. Med. Chem. 2010, 18, 3426-3436.
27. Descamps-François, C.; Yous, S.; Chavatte, P.; Audinot, V.; Bonnaud, A.; Boutin, J.A.; Delagrange, P.; Bennejean, C.; Renard, P.; Lesieur, D. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands. J. Med. Chem. 2003, 46, 1127-1129.
28. Mésangeau, C.; Fraise, M.; Delagrange, P.; Caignard, D.H.; Boutin, J.A.; Berthelot, P.; Yous, S. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio) benzo[b]thiophenes as selective MT2 receptor ligands. Eur. J. Med. Chem. 2011, 46, 1835-1840.
29. Durieux, S.; Chanu, A.; Bochu, C.; Audinot, V.; Coumailleau, S.; Boutin, J.A.; Delagrange, P.; Caignard, D.H.; Bennejean, C.; Renard, P.; et al. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II. Bioorg. Med. Chem. 2009, 17, 2963-2974.
30. Poissonnier-Durieux, S.; Ettaoussi, M.; Pérès, B.; Boutin, J.A.; Audinot, V.; Bennejean, C.; Delagrange, P.; Caignard, D.H.; Renard, P.; Berthelot, P.; et al. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands. Bioorg. Med. Chem. 2008, 16, 8339-8348.
31. Yous, S.; Durieux-Poissonnier, S.; Lipka-Belloli, E.; Guelzim, H.; Bochu, C.; Audinot, V.; Boutin, J.A.; Delagrange, P.; Bennejean, C.; Renard, P.; et al. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Bioorg. Med. Chem. 2003, 11, 753-759.
32. Leclerc, V.; Ettaoussi, M.; Rami, M.; Farce, A.; Boutin, J.A.; Delagrange, P.; Caignard, D.H.; Renard, P.; Berthelot, P.; Yous, S. Design and synthesis of naphthalenic derivatives as new ligands at the melatoninbinding site MT3. Eur. J. Med. Chem. 2011, 46, 1622-1629.
33. Ettaoussi, M.; Péres, B.; Klupsch, F.; Delagrange, P.; Boutin, J.A.; Renard, P.; Caignard, D.H.; Chavatte, P.; Berthelot, P.; Lesieur, D.; et al. Design and synthesis of benzofuranic derivatives as new ligandsat the melatonin-binding site MT3. Bioorg. Med. Chem. 2008, 16, 4954-4562.
34. Leclerc, V.; Yous, S.; Delagrange, P.; Boutin, J.A.; Renard, P.; Lesieur, D. Synthesis of Nitroindole Derivatives with High Affinity and Selectivity for Melatoninergic Binding Sites MT3. J. Med. Chem. 2002, 45, 1853-1859.
35. Yous, S.; Andrieux, J.; Howell, H.E.; Morgan, P.J.; Renard, P.; Pfeiffer, B.; Lessieur, D.; Guardiola-Lemaitre, B. Novel naphthalenic ligands with high affinity for the melatonin receptor. J. Med. Chem. 1992, 35, 1484-1486.
36. Assogba, L.; Ahamada-Himidi, A.; Meddad-Bel Habich, N.; Aoun, D.; Boukli, L.; Massicot, F.; Mounier, C.M.; Huet, J.; Lamouri, A.; Ombetta, J.E.; et al. Inhibition ofsecretoryphospholipase A2. Design, synthesis and structure-Activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s. Eur. J. Med. Chem. 2005, 40, 850-861.
37. Boukli, L.; Touaibia, M.; Meddad-Belhabich, N.; Djimdé, A.; Park, C.H.; Kim, J.J.; Yoon, J.H.; Lamouri, A.; Heymans, F. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: Synthesis and biological activity of 1-Alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol- 5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines. Bioorg. Med. Chem. 2008, 16, 1242-1253.
38. Lenda, F.; Guenoun, F.; Tazi, B.; Ben Larbi, N.; Allouchi, H.; Martinez, J.; Lamaty, F. Synthesis of New Tetrazole-Substituted Pyroaminoadipic and Pipecolic Acid Derivatives. Eur. J. Org. Chem. 2005, 326-333.
39. McKay, A.F.; Braun, R.O. Cyclizationsof ß-Chloroethyl Substituted Amminocarbonic Acids. J. Org. Chem. 1951, 16, 1829-1832.
40. Depreux, P.; Lesieur, D.; Ait Mansour, H.; Morgan, P.; Howell, H.E.; Renard, P.; Caignard, D.H.; Pfeiffer, B.; Delagrange, P.; Guardiola, B.; et al. Synthesis and Structure-Activity Relationships of Novel Naphthalenic and Bioisosteric Related Amidic Derivatives as Melatonin Receptor Ligands. J. Med. Chem. 1994, 37, 3231-3239.
41. Mésangeau, C.; Yous, S.; Pérèz, B.; Lesieur, D.; Besson, T. Pictet-Spengler heterocyclizations via microwave-Assisted degradation of DMSO. Tetrahedron Lett. 2005, 46, 2465-2468.
42. Dess, D.B.; Martin, J.C. Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones. J. Org. Chem. 1983, 48, 4155-4156.
43. Audinot, V.; Mailliet, F.; Lahaye-Brasseur, C.; Bonnaud, A.; Le Gall, A.; Amossé, C.; Dromaint, S.; Rodriguez, M.; Nagel, N.; Galizzi, J.P.; et al. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 2003, 36, 7553-7561.